SCHEMBL6530404

SCHEMBL6530404

COc1ccc(Sc2nc(Nc3cccc(F)c3)nc(N[C@@H](CO)CC(C)C)n2)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IDH2 P48735 2/20 0.43
KCNH3 Q9ULD8 6/20 0.43
ALDH1A1 P00352 2/20 0.40
CYP1A2 P05177 1/20 0.40
CYP2D6 P10635 1/20 0.40
CYP2C9 P11712 1/20 0.40
CYP2C19 P33261 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
CHRNA7 P36544 1/20 0.39
MAPT P10636 2/20 0.39
KDM4E B2RXH2 2/20 0.39
NPSR1 Q6W5P4 2/20 0.39
CDK1 P06493 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
TP53 P04637 1/20 0.39
POLB P06746 1/20 0.39
MEN1 O00255 1/20 0.38
RAD52 P43351 1/20 0.38
KMT2A Q03164 1/20 0.38
GBA1 P04062 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6527570 1.00 IDH2 (0.43) IDH2KCNH3ALDH1A1CYP1A2CYP2D6
SCHEMBL6508192 0.86 KCNH3 (0.41) KCNH3ALDH1A1CYP1A2CYP2D6CYP2C9
SCHEMBL6508189 0.86 KCNH3 (0.41) KCNH3ALDH1A1CYP1A2CYP2D6CYP2C9
SCHEMBL6528931 0.86 KCNH3 (0.41) KCNH3ALDH1A1CYP1A2CYP2D6CYP2C9
SCHEMBL6528847 0.86 SYK (0.43) KCNH3ALDH1A1CYP1A2CYP2D6CYP2C9
SCHEMBL6530945 0.86 KCNH3 (0.59) KCNH3ALDH1A1CYP1A2CYP2D6CYP2C9
SCHEMBL6531320 0.85 ALDH1A1 (0.45) IDH2KCNH3ALDH1A1CYP1A2CYP2D6
SCHEMBL6531002 0.84 ALDH1A1 (0.49) IDH2KCNH3ALDH1A1CYP1A2CYP2D6
SCHEMBL6529816 0.83 KCNH3 (0.43) KCNH3ALDH1A1CYP1A2CYP2D6CYP2C9
SCHEMBL6528850 0.82 AAK1 (0.42) CHRNA7MAPTTP53POLBMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005003103-A2 2, 4, 6-TRI-SUBSTITUTED 6-MEMBERED HETEROCYCLES AND THEIR USE IN THE TREATMENT OF NEURODEGENERATIVE DISEASES ASTRAZENECA AB (SE) 2005-01-13 WO claimed
WO-2005003103-A2 2, 4, 6-TRI-SUBSTITUTED 6-MEMBERED HETEROCYCLES AND THEIR USE IN THE TREATMENT OF NEURODEGENERATIVE DISEASES ASTRAZENECA AB (SE) 2005-01-13 WO disclosed